Krebs Biochemicals & Industries Ltd.

KREBSBIO

₹76.79

-2.04% (-1.6)

Market Cap

₹166 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

166 Cr

Prom Holding

72.74 %

ROE (%)

16.57

ROCE (%)

-12.93

Div Yield (%)

Sales

43.31 Cr

OPM (%)

-34.70 %

Debt to Equity

-1.62

Edit Ratio's

About

Krebs Biochemicals & Industries Limited (KBIL) is a pharma company based in India that special… Read more

Low

52W Range

High

129

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Working Capital

Working capital of the company seems to be under control
ROE

Financial leverage has increased roe over 10 years
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Krebs Biochemicals & Industries Ltd. Business

What does Krebs Biochem.&Inds do?

Krebs Biochemicals & Industries Limited is an India-based pharmaceutical company specializing in fermentation technology. They produce products like lavastatin and simvastatin.

Who are the competitors of Krebs Biochem.&Inds?

Krebs Biochem.&Inds major competitors are Murae Organisor, Denis Chem Lab, Coral Laboratories, Alpa Lab, Panchsheel Organics, Achyut Healthcare, Bharat Immunological.
Market Cap of Krebs Biochem.&Inds is ₹166 Crs.
While the median market cap of its peers are ₹144 Crs.

Is Krebs Biochem.&Inds financially stable compared to its competitors?

Krebs Biochem.&Inds seems to be less financially stable compared to its competitors.
Altman Z score of Krebs Biochem.&Inds is -1.09 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Krebs Biochemicals & Industries Ltd.

View the discussion on ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

2 Neutral

8 No

1 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Retail Holding

Promoter Holding

Depreciation Effect

Revenue Recognition

Price & Performance

Capex vs ROCE

Working Capital

ROE

Debt

Share price

Sales Growth

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Break-Up

UNLOCK PREMIUM

What does Krebs Biochem.&Inds do?

Who are the competitors of Krebs Biochem.&Inds?

Is Krebs Biochem.&Inds financially stable compared to its competitors?

Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

2 Neutral

8 No

1 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Retail Holding

Promoter Holding

Depreciation Effect

Revenue Recognition

Price & Performance

Capex vs ROCE

Working Capital

ROE

Debt

Share price

Sales Growth

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Break-Up

UNLOCK PREMIUM

What does Krebs Biochem.&Inds do?

Who are the competitors of Krebs Biochem.&Inds?

Is Krebs Biochem.&Inds financially stable compared to its competitors?

SIGN UP FOR FREE